At Theranib Inc., we are dedicated to revolutioning cancer treatment by addressing the most pressing challenges in oncology: chemotherapy resistance and metastasis. Through our groundbreaking research and development of ALDH1A3-targeted therapies, we aim to deliver life-changing solutions for patients worldwide.
Founded by leading scientists from Dalhousie University in Nova Scotia, Canada, and the University of Pisa, Italy, Theranib combines world-class expertise in molecular cancer biology and medicinal chemistry. Our proprietary compound, CLM296, represents a first-in-class therapeutic innovation designed to enhance the effectiveness of cancer treatments and improve patient outcomes.
Supported by key funding sources, including the Canadian Institutes of Health Research and Invest Nova Scotia, we are advancing our mission to set a new standard in precision medicine. With a strong commitment to innovation and collaboration, Theranib is paving the way for the future of cancer care.
Company Details
- Employees
- 1
- Founded
- 2023
- Address
- 1300-1969 Upper Water Street, Mcinnes Cooper Tower, Halifax,nova Scotia Ns B3j 3r7,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://theranib.com/
- HQ
- Halifax, Nova Scotia
Theranib Inc. Questions
Theranib Inc.'s website is https://theranib.com/
Theranib Inc.'s LinkedIn profile is https://ca.linkedin.com/company/theranib-inc
Theranib Inc. has
1 employees.
View email and phone details for 1
employees at Theranib Inc..
Theranib Inc.'s industry is
Biotechnology Research
Theranib Inc.'s top competitors are
48hour Discovery,
Rhythm Biotherapeutics Inc.,
Stereo Biotherapeutics,
3dbiofibr Inc.,
Ribozome,
Htuo Biosciences,
Ring Rescue Inc.,
Sona Nanotech Inc.,
Lab 4 Inc.,
Pina Creation Inc..
Theranib Inc.'s categories are Biotechnology Research
Theranib Inc.'s founding year is 2023
